Free Trial
TSE:VBV

VBI Vaccines (VBV) Stock Price, News & Analysis

VBI Vaccines logo
C$4.82
-0.26 (-5.12%)
(As of 03/23/2018)

About VBI Vaccines Stock (TSE:VBV)

Key Stats

Today's Range
C$4.82
C$5.05
50-Day Range
N/A
52-Week Range
C$3.85
C$7.60
Volume
1,300 shs
Average Volume
3,637 shs
Market Capitalization
C$308.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines that closely mimic the target virus. It is also developing congenital cytomegalovirus vaccine candidate for infectious disease; and therapeutic glioblastoma multiforme vaccine candidate for immuno-oncology. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts. VBI Vaccines Inc. is a subsidiary of FDS Pharma ASS.

Receive VBV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter.

VBV Stock News Headlines

VBIVQ VBI Vaccines Inc.
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
VBI Vaccines Inc VBIV
See More Headlines

VBV Stock Analysis - Frequently Asked Questions

VBI Vaccines' stock was trading at C$4.82 on January 1st, 2024. Since then, VBV shares have increased by 0.0% and is now trading at C$4.82.
View the best growth stocks for 2024 here
.

Shares of VBV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that VBI Vaccines investors own include Adobe (ADBE), Actinium Pharmaceuticals (ATNM), Inovio Pharmaceuticals (INO), Teladoc Health (TDOC), Tesla (TSLA), VBI Vaccines (VBIV) and Altimmune (ALT).

Industry, Sector and Symbol

Industry
Biological Products, Except Diagnostic Substances
Sub-Industry
Pharmaceutical Products
CIK
N/A
Fax
N/A
Employees
22
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$3.36 million
Book Value
C$1.01 per share

Miscellaneous

Free Float
N/A
Market Cap
C$308.86 million
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (TSE:VBV) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners